Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Mar 11
Love0

Exploring the Therapeutic Potential of GLP-1 Agonists in Hidradenitis Suppurativa

By Chuck Lin No Comments
INTRODUCTIONHidradenitis Suppurativa (HS) is a notoriously difficult-to-treat inflammatory skin condition characterized by the presence of deep, painful nodules, abscesses, tracts, and fibrotic scars, often occurring in intertriginous and apocrine gland-rich…
Read More
Mar 07
Love0

A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies

By Chuck Lin No Comments
INTRODUCTIONGlucagon-like peptide-1 (GLP-1) agonists are used to treat type 2 diabetes mellitus (T2DM) and have recently gained approval and popularity for treating obesity and weight loss. With the recent increase…
Read More
Mar 01
Love0

Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

By Chuck Lin No Comments
INTRODUCTION Socioeconomic development is associated with cancer's prevalence and distribution. According to the GLOBOCAN Estimates of Incidence and Mortality Worldwide, the estimated incidence rate (ASR) for males and females in…
Read More
Feb 28
Love0

Effects on the Skin Microbiome by a Moisturizer Formulated for Eczema-Prone and Sensitive Skin

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a common, chronic inflammatory skin disease for which cutaneous dysbiosis is a core component of disease pathophysiology.1,2 AD-associated dysbiotic changes in the skin microbiome composition include…
Read More
Feb 28
Love0

Alopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and Outcomes

By Chuck Lin No Comments
INTRODUCTIONImmune checkpoints are inhibitory pathways within the immune system that maintain self-tolerance and regulate the duration and strength of immune responses.1 Tumors can exploit this mechanism to evade immune surveillance…
Read More
Feb 28
Love0

The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature

By Chuck Lin No Comments
INTRODUCTION Acne is the most common cutaneous disease worldwide and the most frequent disorder to present to the dermatology practice. Although efficacious treatments exist, clinicians continue to search for better…
Read More
Feb 28
Love0

INDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events

By Chuck Lin No Comments
INTRODUCTIONIn 2024, an estimated >200,000 new cases of cancer will be diagnosed in Nordic Europeans. Apart from non-melanoma skin cancer, the 4 most commonly diagnosed cancers are prostate, breast, lung,…
Read More
Feb 28
Love0

FULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom) 5: A Practical Algorithm for the Treatment And Supportive Management of Cutaneous Adverse Events in Patients Receiving Targeted Therapy for Cancer

By Chuck Lin No Comments
In this issue NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse EventsIn 2024, an estimated >200,000 new cases of cancer will be diagnosed in Nordic…
Read More
Feb 28
Love0

INDIVIDUAL ARTICLE: A Clinical Evaluation of Scalp Barrier Function, Ceramide Levels, and Microbiome in Diverse Dandruff Patients

By Chuck Lin No Comments
INTRODUCTIONSeborrheic dermatitis (SD) and dandruff are of a continuous spectrum of the same disease that affects the seborrheic areas of the body, with dandruff being milder and specifically localized to…
Read More
Feb 28
Love0

FULL SUPPLEMENT: Exploring The Scalp Barrier and Microbiome In Diverse Dandruff Patients

By Chuck Lin No Comments
In this issue: A Clinical Evaluation of Scalp Barrier Function, Ceramide Levels, and Microbiome in Diverse Dandruff Patients Seborrheic dermatitis (SD) and dandruff are of a continuous spectrum of the…
Read More
Feb 28
Love0

TikTok as a Source of Information for Seborrheic Dermatitis: A Cross-Sectional Analysis

By Chuck Lin No Comments
Dear Editor, Seborrheic dermatitis (SD) is a persistent inflammatory skin condition, marked by red scaly patches primarily on the scalp, nasal area, and chest, often with itching and flaking.1 Despite…
Read More
Feb 28
Love0

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

By Chuck Lin No Comments
INTRODUCTION Generalized pustular psoriasis (GPP) is a rare skin condition with prevalence rates ranging from 2 to 124 cases per million persons characterized by potentially disfiguring and painful erythematous, exudate-filled…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Socioeconomic Disparities in Gentle Skin Care Access for Atopic Dermatitis: Affordability and Pharmacy Deserts June 26, 2025
  • World Vitiligo Day June 25, 2025
  • Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey June 24, 2025
  • Dermatology Roundup: Drug Class Effective Against Treatment-Resistant Melanoma June 23, 2025
  • JDD in the News: Proposed Universal Classification System for Topical Corticosteroids  June 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search